A Peptide-Hormone-Inactivating Endopeptidase in Xenopus Laevis Skin Secretion

Total Page:16

File Type:pdf, Size:1020Kb

A Peptide-Hormone-Inactivating Endopeptidase in Xenopus Laevis Skin Secretion Proc. Nati. Acad. Sci. USA Vol. 89, pp. 84-88, January 1992 Biochemistry A peptide-hormone-inactivating endopeptidase in Xenopus laevis skin secretion (metailoendopeptidase/neutral endopeptidase/thermolysin) KRISHNAMURTI DE MORAIS CARVALHO*, CARINE JOUDIOU, HAMADI BOUSSETTA, ANNE-MARIE LESENEY, AND PAUL COHEN Groupe de Neurobiochimie Cellulaire et Moldculaire de l'Universitd Pierre et Marie Curie, Unit6 de Recherche Associ6e 554 au Centre National de la Recherche Scientifique, % Boulevard Raspail, 75006 Paris, France Communicated by I. Robert Lehman, September 16, 1991 ABSTRACT An endopeptidase was isolated from Xenopus Indeed the Ser-Phe dipeptide, or a related motif such as laevis skin secretions. This enzyme, which has an apparent Phe-Phe, Ala-Phe, or His-Phe, is often present near the molecular mass of 100 kDa, performs a selective cleavage at the carboxyl terminus of substances from the bombesin and Xaa-Phe, Xaa-Leu, or Xaa-Ile bond (Xaa = Ser, Phe, Tyr, His, tachykinin families (1). Xaa-Phe, Xaa-Leu, or Xaa-Ile was or Gly) of a number of peptide hormones, including atrial also found frequently at a similar position in other peptide natriuretic factor, substance P, angiotensin H, bradykinin, hormone sequences of higher organisms, notably in atrial somatostatin, neuromedins B and C, and litorin. The peptidase natriuretic factor (ANF). exhibited optimal activity at pH 7.5 and aKm in the micromolar We have purified this enzyme 2029-fold and demonstrate range. No cleavage was produced in vasopressin, ocytocin, that it inactivates ANF by exclusive cleavage of the Ser25- minigastrin I, and [Leu5Jenkephalin, which include in their Phe26 bond and similarly inactivates a number of important sequence an Xaa-Phe, Xaa-Leu, or Xaa-Ile motif. The en- peptide hormones such as somatostatin, bradykinin, neuro- dopeptidase activity was inhibited by divalent cation chelators medins B and C, litorin, substance P, and angiotensin II. and by phosphoramidon only at high concentrations (ICss = 50 jAM), whereas it was insensitive to classical inhibitors of AND chymotrypsin, angiotensin convertase, and serine and cysteine MATERIALS METHODS peptidases, as well as carboxypeptidases. It is hypothesized that Purification Procedure. Exudates were obtained from three this enzyme, which is distinct from neutral endopeptidase (EC X. laevis (Centre National de la Recherche Scientifique, 3.4.24.11), constitutes the prototype of a family of related Montpellier, France), and submitted to Sephadex G-50, metalloendopeptidases that inactivate peptide substrates by DEAE-Sephadex, and aminoethylagarose hydrophobic ab- cleavage at the Xaa-Phe, Xaa-Leu, or Xaa-fle bond. sorption chromatography as in ref. 3. The fractions contain- ing endopeptidase activity were then applied to a Nucleosil A rather limited number ofpeptidases seem to be involved in C4 300-A (8 x 75 mm) HPLC column (SFCC-Shandon, the postsecretory inactivation of peptide hormone messen- Eragny, France) and eluted with 10 mM sodium phosphate/ gers. The importance of these proteolytic mechanisms in 1.5 M sodium chloride buffer, pH 7.4, at a flow rate of 0.5 regulating hormonal action can be demonstrated by the fact ml-min-1, for 10 min followed by a linear gradient from 1.5 to that their effects can be prolonged in vivo or in vitro by 0 M sodium chloride/10 mM sodium phosphate buffer, pH selective inhibitors ofthese enzymes. This has been shown in 7.4, in 10 min. Subsequently, a gradient from 0% to 30% the case of the enkephalin-degrading enzyme neutral en- (vol/vol) methanol in 10 mM sodium phosphate buffer, pH dopeptidase (NEP; enkephalinase, EC 3.4.24.11) and in the 7.4, in 60 min eluted the enzyme, which was recovered at 25% case of angiotensin-converting enzyme (ACE; EC 3.4.15.1). methanol. The purified enzyme was resistant to 30%o meth- Many of these previously identified peptidases cleave with a anol and 1.5 M sodium chloride (90%o of initial activity limited selectivity and sometimes at multiple sites. remained; data not shown). The endopeptidase was com- The skin secretions of Xenopus laevis contain an extraor- pletely separated from the copurifying RXVRG-endopro- dinary number of peptide hormones eliciting a broad spec- tease activity (eluted with 12% methanol). The active frac- trum of biological actions (reviewed in ref. 1). In addition to tions were pooled, concentrated to a 30-,ul final volume, and those substances so far identified exclusively in the batra- analyzed by polyacrylamide gel electrophoresis under either chian skin exudate such as caeruleins, magainins, levitide, nondenaturing or denaturating conditions using the PhastGel PGLa, xenopsin, etc. (1, 2), the secretory glands of these system (Pharmacia) (3, 4). Protein content was evaluated by amphibians can also produce mammalian peptide hormones the method of Bradford (5). and some of their analogs, such as substance P, corti- Enzyme Assays. Endopeptidase activity was monitored as in coliberin, thyroliberin, and angiotensin I. In the course of ref. 3, using as substrate the diaminobenzylthiocyanate isolating the enzyme responsible for the activation of some X. (DABTC) derivative of [DArg8]kermit, a derivative of kermit laevis skin secretion hormone precursors by cleavage at the (Asp-Val-Asp-Glu-Arg-Asp-Val-Arg-Gly-Phe-Ala-Ser-Phe- Arg-Gly bond of a consensus Arg-Xaa-Val-Arg-Gly (RX- Leu-NH2) that undergoes a single cleavage at the Ser12-Phe13 VRG) sequence, we have detected a contaminating proteo- bond. When other peptide hormones were used as substrates, lytic activity (3). This endopeptidase copurifies with the the conditions were as follows: 1-2 nmol of peptide incubated RXVRG-endoprotease of X. laevis skin secretions and cleaves at the Ser-Phe bond situated on the carboxyl side of Abbreviations: NEP, neutral endopeptidase (EC 3.4.24.11); ACE, the RXVRG consensus sequence in a synthetic peptide (3). angiotensin converting enzyme (EC 3.4.15.1); PHIE, peptide- hormone-inactivating endopeptidase; ANF, atrial natriuretic factor; DABTC, diaminobenzylthiocyanate. The publication costs of this article were defrayed in part by page charge *On leave from: Depto de Fisiologia e Farmacologia da Universidade payment. This article must therefore be hereby marked "advertisement" Federal do CearA (UFC), CX Postal 657, Rua Cel Nunes de Melo in accordance with 18 U.S.C. §1734 solely to indicate this fact. 1127, 60.000-Fortaleza, CE, Brazil. 84 Downloaded by guest on September 27, 2021 Biochemistry: Carvalho et al. Proc. Natl. Acad. Sci. USA 89 (1992) 85 1-5 hr in 100 mM sodium phosphate buffer, pH 7.4, in the Phe-Phe, His-Phe, Gly-Leu, His-Leu, or Tyr-Ile bond of the presence of 10 ng ofpure enzyme in 20 pkl. After heating 10 min tested peptides. Hydrolysis of the Ser25-Phe26 bond of ANF- at 1000C, the resulting products were separated by HPLC (5-28) removed the Phe26-Arg27-Tyr28 tripeptide tail and led using a Nucleosil 5-,um C18 column (146 x 4.5 mm) eluted as to stoichiometric amounts of both the NH2-terminal 5-25 described in the legend of Fig. 2. Substrate and product(s) fragment and this tripeptide (fragments a and b, Fig. 2A). For were monitored by UV absorbance at 220 nm and identified by substance P, the major hydrolytic process occurred at the amino acid analysis using a PicoTag station (Waters) or by Gly9-Leu10 bond (fragments a and c, Fig. 2B) and a minor one amino-terminal sequencing (6). Inhibitors were tested at var- at the Phe7-Phe8 doublet (fragments b and d, Fig. 2B). In the ious concentrations (Table 2), using the routine conditions of case ofangiotensin II only one cleavage was produced, at the the endopeptidase assay (see above) and either ANF-(5-28) or Tyr4-Ile5 bond (fragments a and b, Fig. 2C). Bradykinin was [DArg8]kermit as substrate. Inhibitions were expressed as cleaved at the Gly4-Phe5 bond (fragments a and d, Fig. 2D) percentages of the reference activity measured in the absence with a minor cleavage at the Pro7-Phe8 bond (fragments b and of chemical reagents under the same experimental conditions. c, Fig. 2D). Somatostatin-14 undergoes a single cleavage at The pH profile ofendoprotease activity was obtained by using the Phe6-Phe7 bond situated in the disulfide-linked loop ofthe either [DArg8]kermit or ANF-(5-28) as substrate (2 nmol per tetradecapeptide. This resulted in a single product (Fig. 2E) assay) incubated 1 hr with 10 ng of pure enzyme in a 0.1 M (fragment a was identified by NH2-terminal sequencing). In sodium phosphate buffer adjusted to cover a pH range of 5.8 neuromedin C, as well as in neuromedin B and litorin (data to 8.0 (Fig. 4). Under these conditions enzyme kinetics re- not shown), a major hydrolysis was observed at the His8- mained linear, indicating that the endopeptidase was stable at Leu9 or His8-Phe9 bond (fragments a and d, Fig. 2F) and a the pH values used. Enzyme and inhibition assays were run on minor cleavage at Gly7-His8 (fragments b and c, Fig. 2F). average two or three times for each peptide. Analysis of The pure enzyme exhibited high affinity toward all the products was performed at least in duplicate. cleaved substrates. Km values in the range of 18-63 ,M were Peptides and Chemicals. [DArg8]kermit, ANF-(24-28), measured toward ANF-(5-28), substance P, somatostatin-14, [Ala2IANF-(24-28), and [His25]ANF-(24-28) were prepared by bradykinin, neuromedin C, and angiotensin II (Fig. 3). solid-phase synthesis (7, 8) on a Multisynthesizer NPS 4000 Other peptides containing a Xaa-Phe, Xaa-Leu, or Xaa-Ile (Neosystem, Strasbourg, France), purified by HPLC, and motif, including ocytocin, vasopressin, minigastrin I, checked as described (4, 9). Chemicals and peptide substrates [Leu5]enkephalin, and its amidated derivative were not cleaved or fragments were from Neosystem or Sigma.
Recommended publications
  • Neuromedin B Receptor Stimulation of Cav3.2 T-Type Ca 2+ Channels In
    Neuromedin B receptor stimulation of Cav3.2 T-type Ca2+ channels in primary sensory neurons mediates peripheral pain hypersensitivity Yuan Zhang 1, 3, #, *, Zhiyuan Qian 1, #, Dongsheng Jiang 2, #, Yufang Sun 3, 5, Shangshang Gao 3, Xinghong Jiang 3, 5, Hua Wang 4, *, Jin Tao 3, 5, * 1 Department of Geriatrics & Institute of Neuroscience, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China; 2 Comprehensive Pneumology Center, Helmholtz Zentrum München, Munich 81377, Germany; 3 Department of Physiology and Neurobiology & Centre for Ion Channelopathy, Medical College of Soochow University, Suzhou 215123, China; 4 Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China; 5 Jiangsu Key Laboratory of Neuropsychiatric Diseases, Soochow University, Suzhou 215123, China # These authors contribute to this work equally Running title: NmbR facilitates Cav3.2 channels Individual email addresses for all authors: Yuan Zhang ([email protected]), Zhiyuan Qian ([email protected]), Dongsheng Jiang ([email protected]), Yufang Sun ([email protected]), Shangshang Gao ([email protected]), Xinghong Jiang ([email protected]), Hua Wang ([email protected]), Jin Tao ([email protected]) *To whom correspondence should be addressed: Dr. Yuan Zhang, Department of Geriatrics & Institute of Neuroscience, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China. E-mail: [email protected] Dr. Hua Wang, Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China. E-mail: [email protected] Dr. Jin Tao, Department of Physiology and Neurobiology & Centre for Ion Channelopathy, Medical College of Soochow University, Suzhou 215123, China. E-mail: [email protected] 1 Abstract Background: Neuromedin B (Nmb) is implicated in the regulation of nociception of sensory neurons.
    [Show full text]
  • Plant Protease Inhibitors: a Defense Strategy in Plants
    Biotechnology and Molecular Biology Review Vol. 2 (3), pp. 068-085, August 2007 Available online at http://www.academicjournals.org/BMBR ISSN 1538-2273 © 2007 Academic Journals Standard Review Plant protease inhibitors: a defense strategy in plants Huma Habib and Khalid Majid Fazili* Department of Biotechnology, The University of Kashmir, P/O Naseembagh, Hazratbal, Srinagar -190006, Jammu and Kashmir, India. Accepted 7 July, 2007 Proteases, though essentially indispensable to the maintenance and survival of their host organisms, can be potentially damaging when overexpressed or present in higher concentrations, and their activities need to be correctly regulated. An important means of regulation involves modulation of their activities through interaction with substances, mostly proteins, called protease inhibitors. Some insects and many of the phytopathogenic microorganisms secrete extracellular enzymes and, in particular, enzymes causing proteolytic digestion of proteins, which play important roles in pathogenesis. Plants, however, have also developed mechanisms to fight these pathogenic organisms. One important line of defense that plants have to fight these pathogens is through various inhibitors that act against these proteolytic enzymes. These inhibitors are thus active in endogenous as well as exogenous defense systems. Protease inhibitors active against different mechanistic classes of proteases have been classified into different families on the basis of significant sequence similarities and structural relationships. Specific protease inhibitors are currently being overexpressed in certain transgenic plants to protect them against invaders. The current knowledge about plant protease inhibitors, their structure and their role in plant defense is briefly reviewed. Key words: Proteases, enzymes, protease inhibitors, serpins, cystatins, pathogens, defense. Table of content 1.
    [Show full text]
  • Bombesin Receptors in Distinct Tissue Compartments of Human Pancreatic Diseases Achim Fleischmann, Ursula Läderach, Helmut Friess, Markus W
    0023-6837/00/8012-1807$03.00/0 LABORATORY INVESTIGATION Vol. 80, No. 12, p. 1807, 2000 Copyright © 2000 by The United States and Canadian Academy of Pathology, Inc. Printed in U.S.A. Bombesin Receptors in Distinct Tissue Compartments of Human Pancreatic Diseases Achim Fleischmann, Ursula Läderach, Helmut Friess, Markus W. Buechler, and Jean Claude Reubi Division of Cell Biology and Experimental Cancer Research (AF, UL, JCR), Institute of Pathology, University of Berne, and Department of Visceral and Transplantation Surgery (HF, MWB), Inselspital, University of Berne, Berne, Switzerland SUMMARY: Overexpression of receptors for regulatory peptides in various human diseases is reportedly of clinical interest. Among these peptides, bombesin and gastrin-releasing peptide (GRP) have been shown to play a physiological and pathophysiological role in pancreatic tissues. Our aim has been to localize bombesin receptors in the human diseased pancreas to identify potential clinical applications of bombesin analogs in this tissue. The presence of bombesin receptor subtypes has been evaluated in specimens of human pancreatic tissues with chronic pancreatitis (n ϭ 23) and ductal pancreatic carcinoma (n ϭ 29) with in vitro receptor autoradiography on tissue sections incubated with 125I-[Tyr4]-bombesin or the universal ligand 125I-[D-Tyr6, ␤-Ala11, Phe13, Nle14]-bombesin(6–14) as radioligands and displaced by subtype-selective bombesin receptor agonists and antagonists. GRP receptors were identified in the pancreatic exocrine parenchyma in 17 of 20 cases with chronic pancreatitis. No measurable bombesin receptors were found in the tumor tissue of ductal pancreatic carcinomas, however, GRP receptors were detected in a subset of peritumoral small veins in 19 of 29 samples.
    [Show full text]
  • Evidence for Two Different Modes of Tripeptide Disappearance in Human Intestine. Uptake by Peptide Carrier Systems and Hydrolysis by Peptide Hydrolases
    Evidence for two different modes of tripeptide disappearance in human intestine. Uptake by peptide carrier systems and hydrolysis by peptide hydrolases. S A Adibi, … , S S Masilamani, P M Amin J Clin Invest. 1975;56(6):1355-1363. https://doi.org/10.1172/JCI108215. Research Article The intestinal fate of two tripeptides (triglycine and trileucine), which differ markedly in solubility and molecular weight, have been investigated by jejunal perfusion in healthy human volunteers. Rates of glycine or leucine uptake from test solutions containing triglycine or trileucine were greater than from test solutions containing corresponding amounts of free glycine or free leucine, respectively. The rate of glycine uptake from a 100 mM triglycine solution was greater than that from a 150 mM diglycine solution. At each infused load of triglycine (e.g., 1,000 mumol/min) the rates (micromoles/minutes per 30 cm) of either triglycine disappearance (810 +/- 40) or glycine absorption (2,208 +/- 122) were markedly greater than the luminal accumulation rates of either diglycine (56 +/- 10) or free glycine (110 +/- 18). The luminal accumulation rate of free leucine during infusion of a 5 mM trileucine solution was over threefold greater than that of free glycine during the infusion of a 5 mM triglycine solution. Luminal fluid exhibited no hydrolytic activity against triglycine, but contained some activity against trileucine. Saturation of free amino acid carrier system with a large load of leucine did not affect glycine absorption rate from a triglycine test solution, but isoleucine markedly inhibited the uptake from a trileucine solution. When the carrier system for dipeptides was saturated with a large amount of glycylleucine, […] Find the latest version: https://jci.me/108215/pdf Evidence for Two Different Modes of Tripeptide Disappearance in Human Intestine UPTAKE BY PEPTIDE CARRIER SYSTEMS AND HYDROLYSIS BY PEPTIDE HYDROLASES SIAMAK A.
    [Show full text]
  • Safety Assessment of Tripeptide-1, Hexapeptide-12, and Related Amides As Used in Cosmetics
    Safety Assessment of Tripeptide-1, Hexapeptide-12, and Related Amides as Used in Cosmetics Status: Draft Report for Panel Review Release Date: February 21, 2014 Panel Meeting Date: March 17-18, 2014 The 2014 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A Hill, Ph.D. James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This report was prepared by Wilbur Johnson, Jr., M.S., Senior Scientific Analyst and Bart Heldreth, Ph.D., Chemist. © Cosmetic Ingredient Review 1620 L STREET, N.W., SUITE 1200 ◊ WASHINGTON, DC 20036-4702 ◊ PH 202.331.0651 ◊ FAX 202.331.0088 ◊ [email protected] Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Wilbur Johnson, Jr. Senior Scientific Analyst Date: February 21, 2014 Subject: Draft Report on Tripeptide-1, Hexapeptide-12, and Related Amides The draft report on palmitoyl oligopeptides was tabled at the March 18-19, 2013 CIR Expert Panel meeting, pending reorganization of the safety assessment. During the meeting, the Panel was provided with a letter from the CIR Science and Support Committee, recommending the creation of a new ingredient group consisting of ingredients for which the peptide sequence is known, namely, tripeptide -1, hexapeptide-12 and specific related amides. This has been done. Additionally, at the March meeting, further information was sought to better understand the extent and manner in which solid-phase peptide synthesis is used to create the peptide portion of ingredients included in the safety assessment.
    [Show full text]
  • TRH-Like Peptides
    Physiol. Res. 60: 207-215, 2011 https://doi.org/10.33549/physiolres.932075 REVIEW TRH-Like Peptides R. BÍLEK1, M. BIČÍKOVÁ1, L. ŠAFAŘÍK2 1Institute of Endocrinology, Prague, Czech Republic, 2Urology Clinic, Beroun, Czech Republic Received September 6, 2010 Accepted October 8, 2010 On-line November 29, 2010 Summary of the leaders working in the area concerning the TRH TRH-like peptides are characterized by substitution of basic research was Professor V. Schreiber from Prague, Czech amino acid histidine (related to authentic TRH) with neutral or Republic, which already in 1959 formulated the acidic amino acid, like glutamic acid, phenylalanine, glutamine, hypothesis that adenohypophyseal acid phosphatase is tyrosine, leucin, valin, aspartic acid and asparagine. The related to thyrotropin secretion and that TRH is its presence of extrahypothalamic TRH-like peptides was reported in possible activator (Schreiber and Kmentova 1959, peripheral tissues including gastrointestinal tract, placenta, neural Schreiber et al. 1962). TRH precursor, human prepro- tissues, male reproductive system and certain endocrine tissues. TRH, consists of 242 amino acid residues, and contains Work deals with the biological function of TRH-like peptides in six separate copies of the TRH progenitor sequence different parts of organisms where various mechanisms may (Satoh and Mori 1994), which determine the primary serve for realisation of biological function of TRH-like peptides as structure of TRH as a tripeptide pyroglutamyl-histidinyl- negative feedback to the pituitary exerted by the TRH-like proline amide. The transcriptional unit of prepro-TRH is peptides, the role of pEEPam such as fertilization-promoting localized on chromosome 3 in humans (three exons peptide, the mechanism influencing the proliferative ability of interrupted by two introns) (Yamada et al.
    [Show full text]
  • Expression of POMC, Detection of Precursor Proteases, and Evidence
    ORIGINAL ARTICLE See related commentary on page 1934 Human Mast Cells in the Neurohormonal Network: Expression of POMC, Detection of Precursor Proteases, and Evidence for IgE-Dependent Secretion of a-MSH Metin Artuc1, Markus Bo¨hm2, Andreas Gru¨tzkau1, Alina Smorodchenko1, Torsten Zuberbier1, Thomas Luger2 and Beate M. Henz1 Human mast cells have been shown to release histamine in response to the neuropeptide a-melanocyte- stimulating hormone (a-MSH), but it is unknown whether these cells express proopiomelanocortin (POMC) or POMC-derived peptides. We therefore examined highly purified human skin mast cells and a leukemic mast cell line-1 (HMC-1) for their ability to express POMC and members of the prohormone convertase (PC) family known to process POMC. Furthermore, we investigated whether these cells store and secrete a-MSH. Reverse transcriptase-PCR (RT-PCR) analysis revealed that both skin mast cells and HMC-1 cells express POMC mRNA and protein. Expression of the POMC gene at the RNA level in HMC-1 cells could be confirmed by Northern blotting. Transcripts for both PC1 and furin convertase were detectable in skin-derived mast cells and HMC-1 cells, as shown by RT-PCR. In contrast, PC2 transcripts were detected only in skin mast cells, whereas transcripts for paired basic amino acid converting enzyme 4 (PACE4) were present only in HMC-1 cells. Radio- immunoassays performed on cell lysates and cell culture supernatants from human skin-derived mast cells disclosed immunoreactive amounts of a-MSH in both fractions. Stimulation with an anti-IgE antibody significantly reduced intracellular a-MSH and increased extracellular levels, indicating IgE-mediated secretion of this neuropeptide.
    [Show full text]
  • Ultraviolet Irradiation on a Pyrite Surface Improves Triglycine Adsorption
    life Article Ultraviolet Irradiation on a Pyrite Surface Improves Triglycine Adsorption Santos Galvez-Martinez and Eva Mateo-Marti * Centro de Astrobiología (CSIC-INTA), Ctra. Ajalvir, Km. 4, 28850 Torrejón de Ardoz, Spain; [email protected] * Correspondence: [email protected]; Tel.: + 34-915-872-973 Received: 27 July 2018; Accepted: 9 October 2018; Published: 25 October 2018 Abstract: We characterized the adsorption of triglycine molecules on a pyrite surface under several simulated environmental conditions by X-ray photoemission spectroscopy. The triglycine molecular adsorption on a pyrite surface under vacuum conditions (absence of oxygen) shows the presence of + two different states for the amine functional group (NH2 and NH3 ), therefore two chemical species (anionic and zwitterionic). On the other hand, molecular adsorption from a solution discriminates the NH2 as a unique molecular adsorption form, however, the amount adsorbed in this case is higher than under vacuum conditions. Furthermore, molecular adsorption on the mineral surface is even favored if the pyrite surface has been irradiated before the molecular adsorption occurs. Pyrite surface chemistry is highly sensitive to the chemical changes induced by UV irradiation, as XPS analysis shows the presence of Fe2O3 and Fe2SO4—like environments on the surface. Surface chemical changes induced by UV help to increase the probability of adsorption of molecular species and their subsequent concentration on the pyrite surface. Keywords: pyrite; triglycine; XPS; peptide; sulfide mineral; UV; surface; adsorption; prebiotic chemistry 1. Introduction Minerals can be very promising surfaces for studying biomolecule surface processes, which are of principal relevance in the origin of life and a source of chemical complexity [1,2].
    [Show full text]
  • Thesis Submitted for the Degree of Doctor of Philosophy By
    A Study of the Primary Inactivating Enzymes of Thyroliberin in the Synaptosomal Membranes of Bovine Brain Thesis Submitted for the Degree of Doctor of Philosophy By Rhona O’Leary B.Sc. Under the Supervision of Dr. Brendan O’Connor School of Biological Sciences Dublin City University March 1994 I declare that all the work reported in this thesis was performed by Rhona O'Leary, unless otherwise stated. Rhona O’Leary This work is dedicated to my parents, Michael and Nannette, for their endless support, encouragement and love long may it continue. He Wishes For The Cloths Of Heaven Had I the heavens’ embroidered cloths, Enwrought with golden and silver light, The blue and the dim and the dark cloths Of night and light and the half-light, I would spread the cloths under your feet: But I, being poor, have only my dreams; I have spread my dreams under your feet; Tread softly because you tread on my dreams. c. W .B.Yeats Acknowledgements I would like to thank my supervisor, Dr. Brendan O’Connor, for all his help, encouragement, support and friendship over the past five years. His amazing ability to always be good- humoured, understanding and positive-thinking was so much appreciated. Thanks also to my ‘lab-mates’, Philip, Damian and S6 an for their help with just about everything. I especially would like to thank Dr. Gerry Doherty, BRI, for all his help - the world of biochemistry is losing an excellent scientist when he leaves to further his work for a better and greener world. Thanks must also go to Dr.
    [Show full text]
  • Receptor-Bound Somatostatin and Epidermal Growth Factor Are Processed Differently in GH4C1 Rat Pituitary Cells David H
    Receptor-bound Somatostatin and Epidermal Growth Factor Are Processed Differently in GH4C1 Rat Pituitary Cells David H. Presky, and Agnes Schonbrunn Department of Pharmacology, Harvard Medical School, and Laboratory of Toxicology, Harvard School of Public Health, Boston, Massachusetts 02115 Abstract. GH4CI cells, a clonal strain of rat pituitary from cells during dissociation incubations at 37"C tumor cells, have high-affinity, functional receptors showed that >90% of prebound ~25I-EGF was released for the inhibitory hypothalamic peptide somatostatin as ~2sI-tyrosine, whereas prebound [125I-Tyrl]SRIF was (SRIF) and for epidermal growth factor (EGF). In this released as a mixture of intact peptide (55%) and 1251- study we have examined the events that follow the tyrosine (45%). Neither chloroquine (0.1 mM), am- initial binding of SRIF to its specific plasma mem- monium chloride (20 mM), nor leupeptin (0.1 mg/ml) brane receptors in GH4C1 cells and have compared increased the amount of [125I-Tyr~]SRIF bound to the processing of receptor-bound SRIF with that of cells at 37"C. Furthermore, chloroquine and leupeptin EGF. When cells were incubated with [125I-Tyr~]SRIF did not alter the rate of dissociation or degradation of at temperatures ranging from 4 to 37"C, >80% of the prebound [12SI-Tyrl]SRIF. In contrast, these inhibitors specifically bound peptide was removed by extraction increased the amount of cell-associated ~2SI-EGF dur- with 0.2 M acetic acid, 0.5 M NaC1, pH 2.5. In con- ing 37"C binding incubations and decreased the subse- trast, the subeellular distribution of receptor-bound quent rate of release of 12sI-tyrosine.
    [Show full text]
  • Neuromedins U and S Involvement in the Regulation of the Hypothalamo–Pituitary–Adrenal Axis
    REVIEW ARTICLE published: 05 December 2012 doi: 10.3389/fendo.2012.00156 Neuromedins U and S involvement in the regulation of the hypothalamo–pituitary–adrenal axis Ludwik K. Malendowicz*, Agnieszka Ziolkowska and Marcin Rucinski Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland Edited by: We reviewed neuromedin U (NMU) and neuromedin S (NMS) involvement in the regulation Hubert Vaudry, University of Rouen, of the hypothalamo–pituitary–adrenal (HPA) axis function. NMU and NMS are structurally France related and highly conserved neuropeptides. They exert biological effects via two GPCR Reviewed by: receptors designated as NMUR1 and NMUR2 which show differential expression. NMUR1 James A. Carr, Texas Tech University, USA is expressed predominantly at the periphery, while NMUR2 in the central nervous system. Gábor B. Makara, Hungarian Elements of the NMU/NMS and their receptors network are also expressed in the HPA Academy of Sciences, Hungary axis and progress in molecular biology techniques provided new information on their *Correspondence: actions within this system. Several lines of evidence suggest that within the HPA axis Ludwik K. Malendowicz, NMU and NMS act at both hypothalamic and adrenal levels. Moreover, new data suggest Department of Histology and Embryology, Poznan University of that NMU and NMS are involved in central and peripheral control of the stress response. Medical Sciences, 6 Swie¸cickiSt., 60-781 Poznan, Poland. Keywords: neuromedin U, neuromedin S, hypothalamus, pituitary, adrenal e-mail: [email protected] INTRODUCTION Identification of specific NMU receptors (NMUR1 and In search for new biologically active peptides, the group of NMUR2) and its anorexigenic action have enhanced interest in Minamino, Kangawa, and Matsuo in the 1980s isolated numerous physiological role of NMU and NMS (Howard et al., 2000; Ida small neuropeptides from porcine spinal cord.
    [Show full text]
  • Diamandis Thesis
    !"!#$ CHEMICAL GENETIC INTERROGATION OF NEURAL STEM CELLS: PHENOTYPE AND FUNCTION OF NEUROTRANSMITTER PATHWAYS IN NORMAL AND BRAIN TUMOUR INITIATING NEURAL PRECUSOR CELLS by Phedias Diamandis A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy. Department of Molecular Genetics University of Toronto © Copyright by Phedias Diamandis 2010 Phenotype and Function of Neurotransmitter Pathways in Normal and Brain Tumor Initiating Neural Precursor Cells Phedias Diamandis Doctor of Philosophy Department of Molecular Genetics University of Toronto 2010 &'(!)&*!% The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain brings promise for the treatment of neurological diseases and has yielded new insight into brain cancer. The complete repertoire of signaling pathways that governs these cells however remains largely uncharacterized. This thesis describes how chemical genetic approaches can be used to probe and better define the operational circuitry of the NSC. I describe the development of a small molecule chemical genetic screen of NSCs that uncovered an unappreciated precursor role of a number of neurotransmitter pathways commonly thought to operate primarily in the mature central nervous system (CNS). Given the similarities between stem cells and cancer, I then translated this knowledge to demonstrate that these neurotransmitter regulatory effects are also conserved within cultures of cancer stem cells. I then provide experimental and epidemiologically support for this hypothesis and suggest that neurotransmitter signals may also regulate the expansion of precursor cells that drive tumor growth in the brain. Specifically, I first evaluate the effects of neurochemicals in mouse models of brain tumors. I then outline a retrospective meta-analysis of brain tumor incidence rates in psychiatric patients presumed to be chronically taking neuromodulators similar to those identified in the initial screen.
    [Show full text]